Literature DB >> 2642291

Technetium-99m-iminodiacetic acid organic anions: review of biokinetics and clinical application in hepatology.

S Krishnamurthy1, G T Krishnamurthy.   

Abstract

Technetium-99m-labeled iminodiacetic acid analogs are a new class of organic anions, taken up and secreted by hepatocyte into hepatic bile by a carrier-mediated organic anion pathway. They provide a new dimension in the assessment of pathophysiology and morphology of the hepatobiliary system. The amount of uptake and the rapidity of its elimination from the liver is dependent upon the structural configuration of the agent as well as the functional integrity of the hepatocyte and the patency of the biliary system. The clinical areas for application are wide and include most of the hepatobiliary diseases. Technetium-99m-iminodiacetic acid, an agent well suited for both planar and single photon tomographic scintigraphy, is ideal for early diagnosis prior to anatomical changes in the hepatobiliary system. The data collection directly from the liver provides quantitation of both regional and global liver diseases. The count-based method for measuring gallbladder emptying overcomes the theoretical disadvantages of geometric tests. Biokinetics and current clinical application of six of the 99mTc-iminodiacetic acid agents are reviewed, and the potential future clinical and research areas of application are indicated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2642291     DOI: 10.1002/hep.1840090123

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  19 in total

1.  Different concentrations of various radiopharmaceuticals in the two main liver lobes: a preliminary study in clinical patients.

Authors:  Hans Jacobsson; Eduard Jonas; Per M Hellström; Stig A Larsson
Journal:  J Gastroenterol       Date:  2005-07       Impact factor: 7.527

2.  Impaired hepatic function in segmental biliary obstruction demonstrated with a receptor-binding radiotracer.

Authors:  Y Inoue; K Machida; N Honda; T Mamiya; T Takahashi; T Kamano; Y Sasaki
Journal:  Ann Nucl Med       Date:  1994-08       Impact factor: 2.668

3.  A novel method for the determination of biliary clearance in humans.

Authors:  Giulia Ghibellini; Brendan M Johnson; Richard J Kowalsky; William D Heizer; Kim L R Brouwer
Journal:  AAPS J       Date:  2004-11-23       Impact factor: 4.009

4.  Complementary role of helical CT cholangiography to MR cholangiography in the evaluation of biliary function and kinetics.

Authors:  Eleni Eracleous; Marios Genagritis; Nicos Papanikolaou; Allayioti Maria Kontou; P Prassopoullos; Haris Chrysikopoulos; Paul Allan; Nicholas Gourtsoyiannis
Journal:  Eur Radiol       Date:  2005-06-08       Impact factor: 5.315

5.  The Impact of Modern Chemotherapy and Chemotherapy-Associated Liver Injuries (CALI) on Liver Function: Value of 99mTc-Labelled-Mebrofenin SPECT-Hepatobiliary Scintigraphy.

Authors:  Stéphanie Truant; Clio Baillet; Viviane Gnemmi; Maxence Fulbert; Anthony Turpin; Sabrina Dardenne; Emmanuelle Leteurtre; Mehdi El Amrani; Sébastien Dharancy; Laurent Dubuquoy; Damien Huglo; Christophe Chesné; François-René Pruvot
Journal:  Ann Surg Oncol       Date:  2020-08-24       Impact factor: 5.344

6.  Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection.

Authors:  Wilmar de Graaf; Krijn P van Lienden; Sander Dinant; Joris J T H Roelofs; Olivier R C Busch; Dirk J Gouma; Roelof J Bennink; Thomas M van Gulik
Journal:  J Gastrointest Surg       Date:  2010-02       Impact factor: 3.452

7.  Cholescintigraphy in the diagnosis and assessment of benign papillary stenosis.

Authors:  B Persson; B Axelsson; H Jacobsson
Journal:  Eur J Nucl Med       Date:  1993-09

8.  Liver transplant rejection and cholestasis: comparison of technetium 99m-diisopropyl iminodiacetic acid hepatobiliary imaging with liver biopsy.

Authors:  C M Engeler; C C Kuni; R Nakhleh; C E Engeler; R P duCret; R J Boudreau
Journal:  Eur J Nucl Med       Date:  1992

9.  Use of tc-99m mebrofenin as a clinical probe to assess altered hepatobiliary transport: integration of in vitro, pharmacokinetic modeling, and simulation studies.

Authors:  Giulia Ghibellini; Elaine M Leslie; Gary M Pollack; Kim L R Brouwer
Journal:  Pharm Res       Date:  2008-05-30       Impact factor: 4.200

Review 10.  Issues to be considered to address the future liver remnant prior to major hepatectomy.

Authors:  Yoji Kishi; Jean-Nicolas Vauthey
Journal:  Surg Today       Date:  2020-09-07       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.